- Home
- CGEN
CGEN
Compugen Ltd.
as 07-26-2024 4:00pm EST
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
| Founded: | N/A | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 157.6M | IPO Year: | 2000 |
| Target Price: | $7.00 | AVG Volume (30 days): | 285.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.53 - $3.03 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 15.92% | Revenue Growth (next year): | -27.91% |
Latest Compugen Ltd. News
CGEN Breaking Stock News: Dive into CGEN Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024
Zacks
10 days ago
Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data
Zacks
14 days ago
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
Zacks
16 days ago
Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View
Simply Wall St.
25 days ago
The past three years for Compugen (NASDAQ:CGEN) investors has not been profitable
PR Newswire
a month ago
Compugen to Present at Upcoming Antibody Industrial Symposium
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
Compare CGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CGEN Compugen Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.